<?xml version="1.0" encoding="UTF-8"?>
<p>In 2015 the Strategic Advisory Group of Experts on immunization could not recommend the routine use of the vaccine for population sub-groups including children aged less than 16 years and pregnant women but emphasized that the use of the vaccine during outbreaks of hepatitis E should be considered [
 <xref rid="pntd.0006807.ref038" ref-type="bibr">38</xref>]. Our findings show that such an intervention, while not as effective as pre-emptive vaccination, could nonetheless have a major impact, particularly if vaccination can be safely extended to high risk groups excluded from vaccine trials. In particular, these results underline the need to prioritise evaluations of the vaccine in pregnant women [
 <xref rid="pntd.0006807.ref039" ref-type="bibr">39</xref>].
</p>
